Non-Life Insurance in New Zealand Market Snapshot to 2020


Non-Life Insurance in New Zealand
Synopsis
Timetric’s 'Non-Non-Life Insurance in New Zealand Key Trends and Opportunities to 2020' report provides a detailed outlook by product category for the New Zealand non-life insurance segment, and a comparison of the New Zealand insurance industry with its regional counterparts.
It provides values for key performance indicators such as written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets and total investment income during the review period (2011–2015) and forecast period (2015–2020).
The report also analyzes distribution channels operating in the segment, gives a comprehensive overview of the New Zealand economy and demographics, explains the various types of natural hazard and their impact on the New Zealand insurance industry, and provides detailed information on the competitive landscape in the country.
The report brings together Timetric’s research, modeling and analysis expertise, giving insurers access to information on segment dynamics and competitive advantages, and profiles of insurers operating in the country. The report also includes details of insurance regulations, and recent changes in the regulatory structure.
 Click here for sample report @http://www.wiseguyreports.com/sample-request/915213-non-life-insurance-in-new-zealand-key-trends-and-opportunities-to-2020
Summary
Timetric’s 'Non-Non-Life Insurance in New Zealand, Key Trends and Opportunities to 2020' report provides in-depth market analysis, information and insights into the New Zealand non-life insurance segment, including:
• The New Zealand non-life segment’s detailed outlook by product category
• A comprehensive overview of the New Zealand economy and demographics
• A comparison of the New Zealand non-life insurance segment with its regional counterparts
• The various distribution channels in the New Zealand non-life insurance segment
• Detailed analysis of natural hazards and their impact on the New Zealand insurance industry
• Details of the competitive landscape in the New Zealand non-life insurance segment
• Details of regulatory policy applicable to the New Zealand insurance industry
Scope
This report provides a comprehensive analysis of the non-life insurance segment in New Zealand:
• It provides historical values for the New Zealand non-life insurance segment for the report’s 2011–2015 review period, and projected figures for the 2015–2020 forecast period.
• It offers a detailed analysis of the key categories in the New Zealand non-life insurance segment, and market forecasts to 2020.
• It provides a comparison of the New Zealand non-life insurance segment with its regional counterparts
• It analyzes the various distribution channels for non-life insurance products in New Zealand.
• It analyzes various natural hazards and their impact on the New Zealand insurance industry
• It profiles the top non-life insurance companies in New Zealand, and outlines the key regulations affecting them.
Reasons To Buy
• Make strategic business decisions using in-depth historic and forecast market data related to the New Zealand non-life insurance segment, and each category within it.
• Understand the demand-side dynamics, key market trends and growth opportunities in the New Zealand non-life insurance segment.
• Assess the competitive dynamics in the non-life insurance segment.
• Identify growth opportunities and market dynamics in key product categories.
• Gain insights into key regulations governing the New Zealand insurance industry, and their impact on companies and the industry's future.
Key Highlights
• Property insurance was the largest category, accounting for 42.0% of the segment’s gross written premium in 2015.
• Agriculture plays an important role in New Zealand’s economy. Insurers in New Zealand provide a range of insurance options for farmers and farm assets.
• Cybersecurity insurance is an emerging trend in New Zealand. Legislation regarding cyber-risks is still evolving in New Zealand.
• Motor insurance premium prices remain stable throughout the review period. Customers with good claims histories or who invested in fleet risk-management programs received premium discounts.
• The country-wide distribution networks and high levels of customer trust of brokers supported the growth of insurance penetration and demand for non-life insurance.
• New Zealand’s life insurance segment is highly competitive, in the presence of both domestic and foreign insurers.
Table of Contents
1 Key Facts and Highlights
2 Executive Summary
3 Economy and Demographics
4 Segment Outlook
    4.1 Regional Comparison
    4.2 Segment Indicators
      4.2.1 Gross written premium and penetration
      4.2.2 Claims
      4.2.3 Profitability
      4.2.4 Assets and investments 
Continued
For Detailed Reading Please visit @https://www.wiseguyreports.com/reports/915213-non-life-insurance-in-new-zealand-key-trends-and-opportunities-to-2020

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)


Comments

Post a Comment

Popular posts from this blog

Hypotension Treatment Market 2018 – 2023 Projected to Grow Radiantly by Top Players Revenue and Growth Rate

Market Overview: Hypotension refers to very low blood pressure and affects people across all age groups. Blood pressure is the force exerted by human blood against the artery walls, while blood is pumped out by the heart. Hypotension is normally characterized by a diastolic pressure that is lower than 60mm Hg. A systolic pressure lower than 90 mm Hg is also typically symptomatic of hypotension. The global hypotension market is propelled by hypotension incidences, diabetes, cardiovascular disorders, and other health issues. When patients suffer from low blood pressure or hypotension, they may feel dizziness while standing up after sitting for long periods of time. This is why, many of them are advised to not rise suddenly and take support/more time to stand up without any discomfort. Hypotension can also result from dehydration, nervous disorders, and endocrine issues. The geriatric population is quite susceptible to suffering from low blood pressure, boosting the rates of hosp...
Read more

Hemostasis and Tissue Sealing Agents Market Forecasts by Industry Drivers, Regions Till 2030

  Market Highlights The global  hemostasis and tissue sealing agents market size  is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. T...
Read more

Stem Cell Manufacturing Market Professional Overview 2022-2030 with Major Vendors Size, Shares and Worldwide Demand

  Stem Cell Manufacturing Market - Highlights The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market CAGR of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period. According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent govern...
Read more